OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea flag South Korea · Delayed Price · Currency is KRW
43,000
+1,350 (3.24%)
Apr 4, 2025, 3:30 PM KST

OliX Pharmaceuticals Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Cash & Equivalents
3,88311,9834,93034,33711,329
Upgrade
Short-Term Investments
-10,00053,00015,00055,000
Upgrade
Trading Asset Securities
8,5313,9423,941420.681,782
Upgrade
Cash & Short-Term Investments
12,41425,92561,87249,75768,111
Upgrade
Cash Growth
-52.11%-58.10%24.35%-26.95%91.64%
Upgrade
Accounts Receivable
03,55853.23--
Upgrade
Other Receivables
907.841,419996.88272.13159.18
Upgrade
Receivables
907.844,9771,050491.49446.57
Upgrade
Inventory
554.26468.41657.17374.13304.17
Upgrade
Prepaid Expenses
1,370244.91,3671,4807.13
Upgrade
Other Current Assets
287.98526.8699136.92178.26
Upgrade
Total Current Assets
15,53432,14265,04652,24069,047
Upgrade
Property, Plant & Equipment
51,38543,91037,23231,5256,180
Upgrade
Long-Term Investments
1,98623,48126,8090.50.45
Upgrade
Other Intangible Assets
1,7051,9812,1072,1342,529
Upgrade
Other Long-Term Assets
639.621,3121,458772.05820.53
Upgrade
Total Assets
71,249102,825132,65186,67278,577
Upgrade
Accrued Expenses
488.52465.36358.62297.8580.04
Upgrade
Short-Term Debt
13,441----
Upgrade
Current Portion of Long-Term Debt
3,572-19,23016,405-
Upgrade
Current Portion of Leases
745.851,065939.87487.8258.63
Upgrade
Current Income Taxes Payable
53.77----
Upgrade
Other Current Liabilities
11,7595,03319,01423,1744,150
Upgrade
Total Current Liabilities
30,0606,56339,54340,3654,488
Upgrade
Long-Term Debt
21,42835,36220,00020,32614,011
Upgrade
Long-Term Leases
5.382,9303,82651.69257
Upgrade
Long-Term Deferred Tax Liabilities
----1,647
Upgrade
Other Long-Term Liabilities
867.987,6343,0806,29612,597
Upgrade
Total Liabilities
52,77752,48966,44967,26533,227
Upgrade
Common Stock
9,2308,0106,8526,8526,771
Upgrade
Additional Paid-In Capital
175,533157,177151,89592,90891,128
Upgrade
Retained Earnings
-167,785-122,910-103,224-84,303-54,379
Upgrade
Comprehensive Income & Other
871.877,1418,8853,0641,765
Upgrade
Total Common Equity
17,84949,41864,40718,52145,286
Upgrade
Minority Interest
623.76481.45295.16886.2765.31
Upgrade
Shareholders' Equity
18,47350,33666,20319,40745,351
Upgrade
Total Liabilities & Equity
71,249102,825132,65186,67278,577
Upgrade
Total Debt
39,19239,35743,99637,27114,527
Upgrade
Net Cash (Debt)
-26,778-13,43317,87612,48753,584
Upgrade
Net Cash Growth
--43.16%-76.70%51.72%
Upgrade
Net Cash Per Share
-1589.87-931.071304.50912.364074.15
Upgrade
Filing Date Shares Outstanding
18.4616.0213.713.713.54
Upgrade
Total Common Shares Outstanding
18.4616.0213.713.713.54
Upgrade
Working Capital
-14,52625,57825,50211,87464,559
Upgrade
Book Value Per Share
966.923084.794700.191351.593344.07
Upgrade
Tangible Book Value
16,14447,43762,30016,38742,756
Upgrade
Tangible Book Value Per Share
874.552961.164546.391195.843157.30
Upgrade
Land
25,46025,74025,74025,740988.21
Upgrade
Buildings
23,0333,3543,3543,3543,115
Upgrade
Machinery
7,4256,4365,5184,4273,330
Upgrade
Construction In Progress
-8,9481,23971.73-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.